Accelerated TMS for MDD
Accelerated Transcranial Magnetic Stimulation for Major Depressive Disorder
Neuronetics
50 participants
Aug 21, 2025
INTERVENTIONAL
Conditions
Summary
An open-label, multi-center, prospective study to evaluate feasibility and efficacy of accelerated TMS for patients with Major Depressive Disorder (MDD).
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
transcranial magnetic stimulation - DASH 36 treatment delivered in 5 days
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07147218